Clinical Trials Directory

Trials / Unknown

UnknownNCT01685970

Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy

Comparison of Using the Same-day 2 Sachets Picosulfate Versus High Volume PEG Bowel Preparation for Afternoon Colonoscopy

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Inje University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Comparison of using the same-day 2 sachets picosulfate versus high volume PEG bowel preparation for afternoon colonoscopy Morning only same-day 2 sachets picosulfate may enhance patient tolerability and have similar bowel cleansing efficacy compared to standard method using high volume split-dose PEG. The investigators aimed to evaluate the efficacy and tolerability of bowel preparation protocols with same-day 2 sachets picosulfate compared to conventional high volume (4L) split-dose for afternoon colonoscopy.

Detailed description

Split-dose PEG (4L) regimens is a standard regimen for bowel preparation because it has better preparation quality and tolerability than single dose 4L PEG regimens. However, although patients drink each 2L separately, the total volume of 4 L PEG is still quite burdensome volume to ingest. In addition, in split dose method, night dose of day before the procedure make patient to suffer from sleep disturbance because of frequent diarrhea and abdominal discomfort. The investigators aimed to evaluate the efficacy and tolerability of bowel preparation protocols with same-day 2 sachets picosulfate compared to conventional high volume (4L) split-dose for afternoon colonoscopy.

Conditions

Interventions

TypeNameDescription
DRUGHigh volume split-dose PEGHigh volume split-dose PEG 2L/2L 2 times before the day and at the day of colonoscopy
DRUG2 sachets of picosulfate2 sachets of picosulfate 2 times for bowel preparation at the day of colonoscopy

Timeline

Start date
2012-09-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2012-09-17
Last updated
2012-09-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01685970. Inclusion in this directory is not an endorsement.